|
|
News Breaks | | | | February 14, 2012 | | 10:39 EDT |  | MHS, ESRX | Express Scripts, Medco climb after report says FTC likely to approve deal
The Federal Trade Commission, or FTC, staff is expected to recommend that the regulator approve Express Scripts' (ESRX) proposed acquisition of its pharmacy benefit management rival, Medco (MHS), according to market intelligence journal MLex, which cited unnamed sources. However, the FTC may still mount a legal challenge to the deal, adds the publication. The agency has been challenging healthcare mergers, and has been especially vigilant in its regulation of the pharmacy benefit management sector, notes MLex. The issue is likely to be decided by FTC Chairman Jon Leibowitz, who worked as Senator Herb Kohl's leading antitrust advisor for years, the publication said. In mid-morning trading, Medco rose $1.39, or 2.28%, to $62.33, while Express Scripts climbed $1.45, or 2.91%, to $51.24. | |
|
News For MHS;ESRX From The Last 14 Days Check below for free stories on MHS;ESRX the last two weeks. |
|
|
| May 22, 2013 | | 10:18 EDT |  | ESRX | Express Scripts management to meet with Leerink
 Subscribe for More Information | | | May 17, 2013 | | 10:42 EDT | | ESRX | Leerink's healthcare technology & distribution analyst holds a conference call
Subscribe for More Information | | | May 13, 2013 | | 10:09 EDT |  | ESRX | On The Fly: Analyst Upgrade Summary
Subscribe for More Information | | | 05:52 EDT | | ESRX | Express Scripts upgraded to Buy from Hold at Jefferies
Subscribe for More Information | |
|
|
|
|
|
|
